SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-21-020476
Filing Date
2021-04-06
Accepted
2021-04-06 20:29:14
Documents
2
Period of Report
2021-04-06

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1638
2 POWER OF ATTORNEY ea139012ex24-1_panacea2.htm EX-24.1 6936
  Complete submission text file 0001213900-21-020476.txt   9904
Mailing Address C/O AMGEN INC ONE AMGEN CENTER DR THOUSAND OAKS CA 91320-1799
Business Address
WILLIAMS DOUGLAS E (Reporting) CIK: 0001184847 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40311 | Film No.: 21810402

Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 966-0807
Panacea Acquisition Corp. II (Issuer) CIK: 0001828989 (see all company filings)

IRS No.: 853457029 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 6770 Blank Checks